Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

TORONTO, March 16, 2020 /PRNewswire/ – Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to ann…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *